Kura Oncology (KURA) Reiterated at Overweight by Cantor Fitzgerald After Webinar on KO-7246

October 14, 2026 7:19 AM

Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Kura Oncology (NASDAQ: KURA).The analyst commented, "Kura and its spin-out ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found